These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 2293982)

  • 1. A decrease in opioid tone amplifies the luteinizing hormone surge in estrogen-treated ovariectomized rats: comparisons with progesterone effects.
    Masotto C; Sahu A; Dube MG; Kalra SP
    Endocrinology; 1990 Jan; 126(1):18-25. PubMed ID: 2293982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen.
    Gabriel SM; Simpkins JW; Kalra SP
    Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that a decrease in opioid tone on proestrus changes the episodic pattern of luteinizing hormone (LH) secretion: implications in the preovulatory LH hypersecretion.
    Allen LG; Hahn E; Caton D; Kalra SP
    Endocrinology; 1988 Mar; 122(3):1004-13. PubMed ID: 3125034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that a decrease in opioid tone may evoke preovulatory luteinizing hormone release in the rat.
    Allen LG; Kalra SP
    Endocrinology; 1986 Jun; 118(6):2375-81. PubMed ID: 3698918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge.
    Sahu A; Crowley WR; Kalra SP
    Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that long-term estrogen treatment disrupts opioid involvement in the induction of pituitary LH surge.
    Fuentes M; Sahu A; Kalra SP
    Brain Res; 1992 Jun; 583(1-2):183-8. PubMed ID: 1504826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in mediobasal hypothalamic and preoptic area opioid ([3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge.
    Jacobson W; Kalra SP
    Endocrinology; 1989 Jan; 124(1):199-206. PubMed ID: 2535804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge.
    Phillips MI; Wang H; Kimura B; Rejtman M; Koduri P; Kalra SP
    Endocrinology; 1993 Apr; 132(4):1637-42. PubMed ID: 8462463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides.
    Xu B; Sahu A; Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1996 Jan; 137(1):78-84. PubMed ID: 8536645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: involvement of neuropeptide Y.
    Bonavera JJ; Kalra PS; Kalra SP
    Endocrinology; 1996 May; 137(5):1956-62. PubMed ID: 8612536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion.
    Berglund LA; Derendorf H; Simpkins JW
    Endocrinology; 1988 Jun; 122(6):2718-26. PubMed ID: 2836173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice.
    Chappell PE; Schneider JS; Kim P; Xu M; Lydon JP; O'Malley BW; Levine JE
    Endocrinology; 1999 Aug; 140(8):3653-8. PubMed ID: 10433223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma norepinephrine during the rat estrous cycle and after progesterone treatment to the ovariectomized estrogen-primed rat.
    Nagle CA; Rosner JM
    Neuroendocrinology; 1976; 22(1):89-96. PubMed ID: 1035969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat.
    Gabriel SM; Berglund LA; Simpkins JW
    Endocrinology; 1986 Feb; 118(2):558-61. PubMed ID: 3510853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of gonadotropin-releasing hormone surges by estrogen. II. Role of cyclic adenosine 3'5'-monophosphate.
    Chappell PE; Lee J; Levine JE
    Endocrinology; 2000 Apr; 141(4):1486-92. PubMed ID: 10746654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids.
    Bonavera JJ; Sahu A; Kalra PS; Kalra SP
    Endocrinology; 1993 Dec; 133(6):2481-7. PubMed ID: 8243268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges.
    Bauer-Dantoin AC; McDonald JK; Levine JE
    Endocrinology; 1992 Dec; 131(6):2946-52. PubMed ID: 1446632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action.
    McMullin TS; Andersen ME; Nagahara A; Lund TD; Pak T; Handa RJ; Hanneman WH
    Toxicol Sci; 2004 Jun; 79(2):278-86. PubMed ID: 15056801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.